Comorbidities Key to Serious Infections With IBD Treatment
Older IBD patients with comorbidities are less likely to be hospitalized due to an infection if they are treated with vedolizumab or ustekinumab than with an anti-TNF agent, suggests a US study.
Medscape Medical News
source https://www.medscape.com/viewarticle/978348?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/978348?src=rss
Comments
Post a Comment